Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey-Reference-Cited by-同舟云学术

Less than half of patients aged 65 years or under with myeloma proceed to transplantation: results of a two region population-based survey

Published:2005-02 Issue:4 Volume:128 Page:510-512
ISSN:0007-1048
Container-title:British Journal of Haematology
language:en
Short-container-title:

Author:

Morris T. C. M.,Velangi Mark,Jackson Graham,Marks David I,Ranaghan Lisa

Publisher

Wiley

Subject

Hematology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2141.2004.05340.x/fullpdf

Reference8 articles.

1. A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du myelome;Attal;New England Journal of Medicine,1996

2. High-dose chemotherapy with haematopoietic stem-cell rescue for multiple myeloma;Child;New England Journal of Medicine,2003

3. Is there a north-south divide in social class inequalities in health in Great Britain? Cross sectional study using data from the 2001 census;Doran;British Medical Journal,2004

4. Analysis of the effect of prior therapy on progenitor cell yield: use of a chemotherapy scoring system;Drake;British Journal of Haematology,1997

5. Impact on survival of high dose therapy with autologous stem cell support in patients younger than 60 years with newly diagnosed multiple myeloma: a population-based study. Nordic myeloma study group;Lenhoff;Blood,2000

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous stem cell transplantation in patients older than 65 years with multiple myeloma: a real-world study;Hematology, Transfusion and Cell Therapy;2023-09

2. Real-world utilisation of ASCT in multiple myeloma (MM): a report from the Australian and New Zealand myeloma and related diseases registry (MRDR);Bone Marrow Transplantation;2021-05-19

3. Regional differences in access to hematopoietic stem cell transplantation among pediatric patients with acute myeloid leukemia;Pediatric Blood & Cancer;2020-04-23

4. Treatment Patterns and Clinical and Economic Outcomes in Patients With Newly Diagnosed Multiple Myeloma Treated With Lenalidomide- and/or Bortezomib-containing Regimens Without Stem Cell Transplant in a Real-world Setting;Clinical Lymphoma Myeloma and Leukemia;2019-10

5. Access to Hematopoietic Stem Cell Transplantation among Pediatric Patients with Acute Lymphoblastic Leukemia: A Population-Based Analysis;Biology of Blood and Marrow Transplantation;2019-06